Commentary and podcast on landmark gene therapy clinical trial for hemophilia B

Jun 25 2013

( Mary Ann Liebert, Inc./Genetic Engineering News ) A recent article in the New England Journal of Medicine showed that Factor IX gene therapy in patients with hemophilia B was able to convert severe hemophilia to moderate or even mild disease. In a timely commentary, Thierry VandenDriessche, Ph.D., methods editor for Human Gene Therapy and Human Gene Therapy Methods says that this clinical …

Related Blogs

    Originally posted 2011-12-14 16:20:29. Republished by Blog Post Promoter

    No responses yet

    Leave a Reply